Angelini Pharma is acquiring Catalyst Pharmaceuticals in a $4.1 billion deal that gives the Italy-based brain medicines company three commercialized rare disease products and entry into the U.S. market. According …
Category:
Health
-
-
The healthcare provider industry isn’t collapsing — but it is fragmenting, according to data from healthcare restructuring firm Gibbins Advisors. The firm published a report last week showing financial strain …
-
Last year, the first of Donald Trump’s second term as President, there were 2214 measles cases, according to U.S. Measles Tracker managed by Johns Hopkins Bloomberg School of Public Health. …
-
Today, patients are responsible for more of their healthcare costs than they used to be. As employers continue to pass along higher premiums and deductibles, leaving families responsible for a …
-
Rosarium Health, a company enabling aging at home, has raised $6 million in seed funding and secured partnerships with several Medicaid and Medicare Advantage plans, the company shared with MedCity …
-
In recent months, federal and state lawmakers have been increasing their scrutiny of private equity’s role in healthcare consolidation and pricing. Policymakers are raising concerns about PE ownership structures they …
-
Bayer is paying $300 million to buy Perfuse Therapeutics, a clinical-stage biotech that offers a new growth opportunity in ophthalmology as the pharmaceutical company’s top eye product weathers declining revenue …
-
Health systems across the country will recognize their nursing staff for National Nurses Week on May 6-12, with everything from team lunches and awards to professional development opportunities. This year’s …
-
Madrigal Pharmaceuticals, maker of the first FDA-approved medicine for the fatty liver disease MASH, has been exploring combinations of that small molecule with other drugs as a way to potentially …
-
Tensions between providers and payers are increasingly spilling into the courtroom, with health systems and provider groups turning to the legal system for relief from what they say are unfair …